Recurrence of moderate to severe ulcerative colitis after fecal microbiota transplantation treatment and the efficacy of re-FMT: a case series

• Published in: BMC gastroenterology Vol. 20; no. 1; pp. 401 - 8
• Main Authors: Dang, Xiao-Fei, Qing-Xi Wang, Yin, Zhao, Sun, Lin, Yang, Wei-Hua
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 26.11.2020; BioMed Central; BMC
• Subjects: Adult; Care and treatment; Colitis, Ulcerative - therapy; Colon; Colonoscopy; Diseases; Fecal Microbiota Transplantation; Fecal microflora; Feces; Female; Gastroenterology; Humans; Inflammation; Inflammatory bowel disease; Inflammatory Bowel Diseases; Intestine; Laboratories; Male; Microbiota; Middle Aged; Pathogenesis; Patient outcomes; Patients; Recurrence; Relapse; Remission; Remission Induction; Transplantation; Treatment Outcome; Ulcerative colitis; Ulcers; China; Recurrence; Remission; Fecal microbiota transplantation; Ulcerative colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD), the pathogenesis of which is complicated, and it is difficult to treat. In recent years, the emerging fecal microbiota transplantation (FMT) has shown good effects in UC treatment and is therefore accepted by increasing numbers o...